CV Sciences (CVSI) Cost of Revenue (2013 - 2026)
CV Sciences (CVSI) reported Cost of Revenue of $673000.0 for Q1 2026, down 7.93% on a YoY basis from $731000.0 in Q1 2025, and down 86.26% sequentially from $4.9 million in Q4 2025.
CV Sciences (CVSI) Cost of Revenue (2013 - 2026) Analysis & Trends
CV Sciences (CVSI) has 14 years of Cost of Revenue data on file, last reported at $673000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cost of Revenue fell 7.93% year-over-year to $673000.0; the trailing twelve-month figure through Mar 2026 stood at $7.6 million (up 30.94% YoY), and the FY2025 full-year result was $7.0 million, down 17.57% from the prior year.
- Cost of Revenue slipped to $673000.0 in Q1 2026, from $4.9 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $4.9 million in Q4 2025 to a low of -$3.9 million in Q4 2023.
- A 5-year average of $1.6 million and a median of $2.2 million in 2022 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue tumbled 269.92% in 2023 and soared 156.3% in 2024, its largest moves.
- Tracing CVSI's Cost of Revenue over 5 years: stood at $2.3 million in 2022, then plunged by 269.92% to -$3.9 million in 2023, then soared by 156.3% to $2.2 million in 2024, then jumped by 121.88% to $4.9 million in 2025, then tumbled by 86.26% to $673000.0 in 2026.
- Business Quant data shows CVSI's Cost of Revenue at $673000.0 in Q1 2026, $4.9 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | 673,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 673,000.00 |
| Mar 31, 2026 | 673,000.00 |
| Dec 31, 2025 | 4.90 Mn |
| Dec 31, 2025 | 4.90 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 371,000.00 |
| Jun 30, 2025 | 371,000.00 |
| Mar 31, 2025 | 731,000.00 |
| Mar 31, 2025 | 731,000.00 |
| Dec 31, 2024 | 2.21 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 2.09 Mn |
| Sep 30, 2024 | 2.09 Mn |
| Jun 30, 2024 | 793,000.00 |
| Jun 30, 2024 | 793,000.00 |
| Mar 31, 2024 | 813,000.00 |
| Mar 31, 2024 | 813,000.00 |
| Dec 31, 2023 | -3.92 Mn |
| Dec 31, 2023 | -3.92 Mn |